rextoro

  1. Nelson Vergel

    FDA rejects approval of second low T product in the past month

    As of September 17, 2014 (last FDA meeting to review requirements for testosterone studies and products), approval of testosterone replacement products has become a lot more difficult in the United States. This was fueled by two flawed studies that linked testosterone to cardiovascular risks and...
Top